New Zealand - engelsk - Medsafe (Medicines Safety Authority)

multichem nz limited - morphine sulfate pentahydrate 15 mg/ml equivalent to morphine 11.28 mg/ml - solution for injection - 15 mg/ml - active: morphine sulfate pentahydrate 15 mg/ml equivalent to morphine 11.28 mg/ml excipient: hydrochloric acid nitrogen sodium chloride water for injection

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

astrazeneca limited - morphine sulfate pentahydrate 15 mg/ml - solution for injection - 15 mg/ml - active: morphine sulfate pentahydrate 15 mg/ml excipient: hydrochloric acid water for injection

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

astrazeneca limited - morphine sulfate pentahydrate 15 mg/ml - solution for injection - 15 mg/ml - active: morphine sulfate pentahydrate 15 mg/ml excipient: hydrochloric acid water for injection

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - morphine sulfate pentahydrate 10 mg/ml - solution for injection - 10 mg/ml - active: morphine sulfate pentahydrate 10 mg/ml excipient: hydrochloric acid sodium chloride water for injection - latest regulatory activity

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - morphine sulfate pentahydrate 30 mg/ml - solution for injection - 30 mg/ml - active: morphine sulfate pentahydrate 30 mg/ml excipient: hydrochloric acid sodium chloride water for injection - latest regulatory activity

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - morphine sulfate pentahydrate 5 mg/ml - solution for injection - 5 mg/ml - active: morphine sulfate pentahydrate 5 mg/ml excipient: hydrochloric acid sodium chloride water for injection - latest regulatory activity

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - morphine sulfate pentahydrate, quantity: 20 mg - tablet, film coated - excipient ingredients: povidone; lactose; magnesium stearate; purified talc; pregelatinised maize starch; titanium dioxide; sunset yellow fcf aluminium lake; polyvinyl alcohol; macrogol 3350; erythrosine aluminium lake - treatment of chronic severe pain of cancer.

USA - engelsk - NLM (National Library of Medicine)

vistapharm, inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 10 mg in 5 ml - morphine sulfate oral solution is indicated for the management of acute and chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. morphine sulfate oral solution 100 mg per 5 ml (20 mg/ml) is indicated for the relief of acute and chronic pain in opioid-tolerant patients. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.2) ], reserve morphine sulfate oral solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia morphine sulfate oral solution is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.4) ]. - acute or severe bronchial asthma in an unmonitored setting or in the absence of resus

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 100 mg - tablet, modified release - excipient ingredients: hyetellose; hypromellose; magnesium stearate; povidone; purified talc; titanium dioxide; iron oxide black; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 60 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; hypromellose; povidone; hyetellose; purified talc; titanium dioxide; sunset yellow fcf aluminium lake; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.